Aspire BioPharma
Growth Stage
Disruptive technology that improves medicine effectivess safely and rapidly
Overview
Raised: $61,400
Total Commitments ($USD)
Platform
Republic
Start Date
11/01/2023
Close Date
01/31/2024
Min. Goal
$150,000
Max. Goal
$5,000,000
Min. Investment
$500
Security Type
Equity - Preferred
Series
Series A
SEC Filing Type
RegCF
Price Per Share
$0.80
Pre-Money Valuation
$352,000,000
Rolling Commitments ($USD)
Status
Active
Reporting Date
12/02/2023
Days Remaining
60
% of Min. Goal
41%
% of Max. Goal
1%
Likelihood of Max
Avg. Daily Raise
$1,981
# of Investors
23
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2021
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Aspire BioPharma, with a valuation of $352 million, is raising funds on Republic. The company has developed its patent-protected disruptive technology that improves the effectiveness of medicine safely and rapidly. Aspire BioPharma’s technology enables the medicine to flow into the bloodstream directly instead of going through the digestive tract and impacting the liver. The first product of Aspire BioPharma will be Instaprin, a novel soluble formulation of aspirin for stroke emergencies and pain management. Kraig Higginson founded Aspire BioPharma in September 2021. The current crowdfunding campaign has a minimum target of $150,000 and a maximum target of $5 million. The campaign proceeds will be used for GMP batch production and clinical trials, professional services, and working capital.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$626 |
$626 |
| ||
| ||
|
Net Income |
$-597,117 |
$-464,173 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$38 |
$185,496 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$4,917,644 |
$185,496 |
|
Short-Term Debt |
$193,881 |
$117,169 |
|
Long-Term Debt |
$3,852,552 |
$0 |
|
Total Liabilities |
$4,046,433 |
$117,169 |
Financials as of: 11/01/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.